155 related articles for article (PubMed ID: 21341276)
1. Pharmacokinetics of dietary cancer chemopreventive compound dibenzoylmethane in rats and the impact of nanoemulsion and genetic knockout of Nrf2 on its disposition.
Lin W; Hong JL; Shen G; Wu RT; Wang Y; Huang MT; Newmark HL; Huang Q; Khor TO; Heimbach T; Kong AN
Biopharm Drug Dispos; 2011 Mar; 32(2):65-75. PubMed ID: 21341276
[TBL] [Abstract][Full Text] [Related]
2. Dibenzoylmethane activates Nrf2-dependent detoxification pathway and inhibits benzo(a)pyrene induced DNA adducts in lungs.
Thimmulappa RK; Rangasamy T; Alam J; Biswal S
Med Chem; 2008 Sep; 4(5):473-81. PubMed ID: 18782044
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect.
Kim EJ; Kim SO; Lee DH; Lim H; Lee MG
Biopharm Drug Dispos; 2001 Apr; 22(3):119-28. PubMed ID: 11745914
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, biodistribution and bioavailability of isoliquiritigenin after intravenous and oral administration.
Qiao H; Zhang X; Wang T; Liang L; Chang W; Xia H
Pharm Biol; 2014 Feb; 52(2):228-36. PubMed ID: 24102672
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse.
Shen G; Khor TO; Hu R; Yu S; Nair S; Ho CT; Reddy BS; Huang MT; Newmark HL; Kong AN
Cancer Res; 2007 Oct; 67(20):9937-44. PubMed ID: 17942926
[TBL] [Abstract][Full Text] [Related]
7. Dibenzoylmethane Protects Against CCl4-Induced Acute Liver Injury by Activating Nrf2 via JNK, AMPK, and Calcium Signaling.
Cao M; Wang H; Guo L; Yang S; Liu C; Khor TO; Yu S; Kong AN
AAPS J; 2017 Nov; 19(6):1703-1714. PubMed ID: 28828752
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of dietary phenethyl isothiocyanate in rats.
Ji Y; Kuo Y; Morris ME
Pharm Res; 2005 Oct; 22(10):1658-66. PubMed ID: 16180123
[TBL] [Abstract][Full Text] [Related]
9. Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.
Lin HS; Ho PC
J Pharm Sci; 2011 Oct; 100(10):4491-500. PubMed ID: 21520090
[TBL] [Abstract][Full Text] [Related]
10. Differential in vivo mechanism of chemoprevention of tumor formation in azoxymethane/dextran sodium sulfate mice by PEITC and DBM.
Cheung KL; Khor TO; Huang MT; Kong AN
Carcinogenesis; 2010 May; 31(5):880-5. PubMed ID: 19959557
[TBL] [Abstract][Full Text] [Related]
11. Disposition of SK&F L-190144 in rats and monkeys after oral, intravenous or ocular administration.
Tang-Liu DD; Richman JB; Lin P; Selim S
Biopharm Drug Dispos; 1993 May; 14(4):313-24. PubMed ID: 8499582
[TBL] [Abstract][Full Text] [Related]
12. Disposition, oral bioavailability, and tissue distribution of zearalenone in rats at various dose levels.
Shin BS; Hong SH; Bulitta JB; Hwang SW; Kim HJ; Lee JB; Yang SD; Kim JE; Yoon HS; Kim DJ; Yoo SD
J Toxicol Environ Health A; 2009; 72(21-22):1406-11. PubMed ID: 20077212
[TBL] [Abstract][Full Text] [Related]
13. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects.
Retlich S; Duval V; Ring A; Staab A; Hüttner S; Jungnik A; Jaehde U; Dugi KA; Graefe-Mody U
Clin Pharmacokinet; 2010 Dec; 49(12):829-40. PubMed ID: 21053992
[TBL] [Abstract][Full Text] [Related]
15. Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats.
Barve A; Chen C; Hebbar V; Desiderio J; Saw CL; Kong AN
Biopharm Drug Dispos; 2009 Oct; 30(7):356-65. PubMed ID: 19722166
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic evaluation and in vitro-in vivo correlation (IVIVC) of novel methylene-substituted 3,3' diindolylmethane (DIM).
Patel AR; Spencer SD; Chougule MB; Safe S; Singh M
Eur J Pharm Sci; 2012 May; 46(1-2):8-16. PubMed ID: 22342559
[TBL] [Abstract][Full Text] [Related]
17. Absolute bioavailability and dose-dependent pharmacokinetic behaviour of dietary doses of the chemopreventive isothiocyanate sulforaphane in rat.
Hanlon N; Coldham N; Gielbert A; Kuhnert N; Sauer MJ; King LJ; Ioannides C
Br J Nutr; 2008 Mar; 99(3):559-64. PubMed ID: 17868493
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of valerenic acid in rats after intravenous and oral administrations.
Sampath C; Haug K; Thanei S; Hamburger M; Derendorf H; Frye R; Butterweck V
Planta Med; 2012 Apr; 78(6):575-81. PubMed ID: 22411722
[TBL] [Abstract][Full Text] [Related]
19. Absorption, protein binding, pharmacokinetics and excretion of the anti-ischemic and anti-hypertensive arylpiperazine derivative CDRI-93/478 in rats.
Lal J; Gupta RC
Arzneimittelforschung; 2008; 58(2):62-70. PubMed ID: 18412019
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
